Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of Adalimumab Response in RA
NCT00234234Phase 4Completed
- Sponsor
- Rouen University Hospital
- Start
- Jan 2006
- Primary completion
- Dec 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Rouen University Hospital. Primary endpoints: Clinical response at 1 year, Structural response at 1 year and 1 more. Started Jan 2006; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00234234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234234.